复合装置与单纯支架移植TEVAR治疗急性B型主动脉夹层伴灌注不良的短期结局比较
该回顾性研究比较了急性(≤14天)复杂性B型主动脉夹层伴灌注不良患者接受单纯支架移植TEVAR(TEVAR队列,41例)与复合装置设计TEVAR(STABLE队列,84例)的30天结局。
要点
- 两组30天全因死亡率、并发症及二次干预率无显著差异。
- 复合装置组腹部主动脉真腔扩张显著大于单纯支架移植组。
核心结论
- 对于急性B型主动脉夹层伴分支血管灌注不良的患者,使用近端支架移植联合远端裸金属主动脉支架的复合装置,相比单纯支架移植,似乎可降低灌注不良相关死亡率。
研究设计与样本
- 回顾性分析,纳入急性(症状发作≤14天)复杂性B型主动脉夹层伴灌注不良的患者。
- TEVAR队列为两家欧洲机构接受单纯支架移植TEVAR的患者(41例;平均年龄58.8±12.7岁;男性78.0%)。
- STABLE队列为在STABLE I可行性研究和STABLE II关键性研究中接受复合装置设计(Cook Medical)TEVAR的患者(84例;平均年龄57.8±11.7岁;男性71.4%)。
- 比较两组术前特征和30天结局(包括死亡、灌注不良相关死亡、并发症和二次干预)。
主要发现
- 就诊时灌注不良的器官系统受累情况相当:肾脏(TEVAR 53.7%,STABLE 57.1%)、胃肠道(41.5% vs 44.0%)、下肢(34.1% vs 52.4%)、脊髓(9.8% vs 2.4%)。
临床怎么用
- 对于急性B型主动脉夹层伴灌注不良的患者,可考虑使用近端支架移植联合远端裸金属主动脉支架的复合装置,以降低灌注不良相关死亡率。
局限性
- 本研究为回顾性分析,TEVAR队列来自两家欧洲机构,STABLE队列来自前瞻性研究,可能存在选择偏倚。
- 样本量较小,部分结局比较的检验效能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to compare short-term outcomes in patients who underwent thoracic endovascular aortic repair (TEVAR) with stent grafts alone or with a composite device design (stent graft plus bare-metal aortic stent) for acute type B aortic dissection in the setting of malperfusion. METHODS: This retrospective analysis included patients with acute (≤14 days of symptom onset) complicated type B dissection in the setting of malperfusion who were treated with stent grafts alone (TEVAR cohort) at two European institutions vs those who underwent TEVAR with a composite device design (Cook Medical, Bloomington, Ind) in the investigational STABLE I feasibility study and STABLE II pivotal study (STABLE cohort). Preoperative characteristics and 30-day outcomes (including mortality, malperfusion-related mortality, morbidity, and secondary interventions) were compared between the two groups. RESULTS: The TEVAR cohort (41 patients; mean age, 58.8 ± 12.7 years; 78.0% male) and the STABLE cohort (84 patients; mean age, 57.8 ± 11.7 years; 71.4% male) were largely similar in preoperative medical characteristics, with more STABLE patients presenting with a history of hypertension (79.8% vs 58.5%; P = .018). The TEVAR and STABLE groups had similar lengths of dissection (451.8 ± 112.7 mm vs 411.8 ± 116.4 mm; P = .10) and similar proximal and distal extent of dissection. At presentation, the two groups exhibited comparable organ system involvement in malperfusion: renal (53.7% TEVAR, 57.1% STABLE), gastrointestinal (41.5% TEVAR, 44.0% STABLE), lower extremities (34.1% TEVAR, 52.4% STABLE), and spinal cord (9.8% TEVAR, 2.4% STABLE). The 30-day rate of all-cause mortality was 17.1% (7/41) in the TEVAR group and 8.3% (7/84) in the STABLE group (P = .22). The 30-day rate of malperfusion-related mortality (deaths from bowel/mesenteric ischemia or multiple organ failure) was 12% (5/41) in the TEVAR group and 2.4% (2/84) in the STABLE group (P = .038). The 30-day morbidity, for the TEVAR and STABLE groups, respectively, included bowel ischemia (9.8% [4/41] vs 2.4% [2/84]; P = .09), renal failure requiring dialysis (7.3% [3/41] vs 9.5% [8/84]; P > .99), paraplegia or paraparesis (4.9% [2/41] vs 3.6% [3/84]; P = .66), and stroke (2.4% [1/41] vs 10.7% [9/84]; P = .16). The occurrence of 30-day secondary intervention was similar in the TEVAR and STABLE groups (7.3% [3/41] vs 7.1% [6/84]; P > .99). True lumen expansion in the abdominal aorta was significantly greater in the STABLE group. CONCLUSIONS: In patients with acute type B aortic dissection in the setting of branch vessel malperfusion, the use of a composite device with proximal stent grafts and distal bare aortic stent appeared to result in lower malperfusion-related mortality than the use of stent grafts alone. The 30-day rates of morbidity and secondary interventions were similar between the groups.
引用
- Sobocinski J, Dias NV, Hongku K, et al. Thoracic endovascular aortic repair with stent grafts alone or with a composite device design in patients with acute type B aortic dissection in the setting of malperfusion. J Vasc Surg. 2019. PMID: 31280979. doi:10.1016/j.jvs.2019.04.478
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。